Jounce Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2015 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Jounce Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2022.
  • Jounce Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2022 was $50.3M.
  • Jounce Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2022 was -$52.2M, a 42.6% increase year-over-year.
  • Jounce Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$52.2M, a 42.6% increase from 2021.
  • Jounce Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$91.1M, a 102% decline from 2020.
  • Jounce Therapeutics, Inc. annual Operating Income (Loss) for 2020 was -$45.1M, a 185% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$52.2M +$38.8M +42.6% Jan 1, 2022 Dec 31, 2022 10-K/A 2023-04-28
2021 -$91.1M -$45.9M -102% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-04-28
2020 -$45.1M -$97.9M -185% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $52.8M +$84.1M Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
2018 -$31.3M -$12.1M -62.9% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 -$19.2M -$4.75M -32.8% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2016 -$14.5M +$15.9M +52.4% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-08
2015 -$30.4M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.